Equities

Alfresa Holdings Corp

Alfresa Holdings Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)2,274.50
  • Today's Change15.00 / 0.66%
  • Shares traded316.50k
  • 1 Year change-4.91%
  • Beta0.2762
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Alfresa Holdings Corporation is a Japan-based holding company primarily engaged in the wholesale of drugs. The Company operates in four business segments. The Pharmaceutical Wholesale segment is engaged in the wholesale of medical products, test reagents, as well as medical equipment and materials. The Self Medication Wholesale segment is engaged in the wholesale of general drugs. The Pharmaceutical Manufacture segment is engaged in the manufacture and sale of pharmaceuticals, test reagents, medical equipment and implements, as well as pharmaceutical powders. The Medical-Related segment is mainly engaged in operation of pharmacies. The others business is engaged in the information system business, the transportation business, the warehousing business, the insurance agency business, the real estate management business, the sale of miscellaneous goods, as well as the manpower dispatching business, among others.

  • Revenue in JPY (TTM)2.89tn
  • Net income in JPY31.77bn
  • Incorporated2003
  • Employees12.52k
  • Location
    Alfresa Holdings Corp23F, Ote Center Bldg., 1-1-3, Ote-machiCHIYODA-KU 100-0004JapanJPN
  • Phone+81 352195100
  • Fax+81 352195103
  • Websitehttps://www.alfresa.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Japan Lifeline Co., Ltd.54.24bn7.92bn96.52bn1.22k11.791.6310.081.78108.04108.04738.09779.230.77591.414.0744,602,800.0011.338.6314.0210.8860.3257.2814.6012.281.62--0.088548.80-0.70732.459.06-0.54465.407.69
HOGY MEDICAL CO., LTD.39.18bn2.94bn104.00bn1.41k37.041.3111.452.65124.61124.611,651.563,515.340.38962.693.1127,828,840.002.924.243.214.6731.8639.767.5011.583.80--0.162145.680.30531.30-35.03-14.247.944.56
Menicon Co Ltd118.64bn4.84bn119.18bn4.22k25.651.379.201.0060.6260.621,495.581,132.000.66152.858.6828,106,370.002.704.533.365.6753.4152.974.085.721.28109.350.458327.125.447.51-38.484.8832.6112.30
PHC Holdings Corp360.94bn-6.34bn123.31bn9.25k--0.96335.500.3416-50.71-50.712,859.741,013.240.65873.485.6739,042,080.00-1.17-0.0766-1.55-0.116445.4747.71-1.78-0.12680.82380.70740.6779---0.710913.66-300.16--16.68--
Paramount Bed Holdings Co Ltd104.97bn7.60bn156.80bn4.13k19.311.078.631.49131.51131.511,817.752,368.090.59474.544.6625,441,110.004.305.594.926.5947.8546.917.249.593.70--0.046936.657.085.7715.279.6416.645.39
Mani Inc28.51bn6.29bn187.74bn3.69k27.493.3027.716.5863.8263.82289.47531.170.50851.6611.99--11.2110.6812.0911.4762.7763.1122.0523.776.54--0.001658.3416.449.245.590.596642.0720.53
NAKANISHI INC.75.10bn8.53bn209.35bn2.05k22.331.6314.832.79100.34100.34882.281,373.410.52841.329.4036,650,630.006.0012.717.0614.0256.7561.4111.3626.602.0828.800.12928.1222.6410.3183.1024.6511.2812.30
Ship Healthcare Holdings Inc644.25bn15.64bn216.25bn7.79k12.821.439.520.3357165.87165.876,828.271,488.271.7519.025.5982,670,220.004.173.638.066.869.9510.522.392.291.28--0.24632.0010.267.2814.314.183.095.15
As One Corp100.05bn7.77bn225.46bn711.0026.213.0923.522.25107.86107.861,388.57915.841.086.213.31140,717,100.008.407.6111.1110.4930.1330.797.778.162.17--0.042251.114.507.44-7.557.345.959.70
Nipro Corp612.94bn1.31bn237.99bn38.12k322.990.87113.600.38834.304.303,531.311,593.390.54021.823.6916,080,410.000.22680.79230.3551.2129.3429.990.41981.450.79391.730.690860.827.636.59142.87-1.7510.97-2.24
Fukuda Denshi Co Ltd138.10bn16.59bn276.31bn3.44k12.931.2310.292.00565.94565.944,709.895,965.540.66463.944.0940,109,210.007.988.079.3410.1751.5747.8312.0111.133.59--0.010429.094.211.588.1914.3111.0015.85
NIHON KOHDEN CORPORATION221.23bn9.49bn371.76bn5.89k38.122.0527.361.6857.0457.041,321.401,058.571.011.873.8737,554,580.004.328.665.3411.4050.2950.854.298.412.797.280.002727.527.454.42-0.49098.758.0511.75
Alfresa Holdings Corporation2.89tn31.77bn458.32bn12.52k13.290.859810.030.1588169.96169.9615,444.132,628.072.0016.854.37230,646,200.002.172.276.015.937.267.251.091.131.05--0.057637.856.021.6014.63-6.662.327.39
Data as of Nov 22 2024. Currency figures normalised to Alfresa Holdings Corp's reporting currency: Japanese Yen JPY

Institutional shareholders

26.02%Per cent of shares held by top holders
HolderShares% Held
Silchester International Investors LLPas of 14 Nov 202320.91m10.31%
Nomura Asset Management Co., Ltd.as of 07 Nov 20246.35m3.13%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 13 Sep 20245.77m2.84%
The Vanguard Group, Inc.as of 06 Nov 20245.53m2.73%
Nikko Asset Management Co., Ltd.as of 13 Sep 20243.13m1.54%
Daiwa Asset Management Co. Ltd.as of 31 Oct 20242.74m1.35%
Norges Bank Investment Managementas of 30 Jun 20242.68m1.32%
BlackRock Fund Advisorsas of 07 Nov 20242.06m1.02%
Geode Capital Management LLCas of 30 Sep 20241.90m0.94%
Mitsubishi UFJ Asset Management Co., Ltd.as of 11 Mar 20241.72m0.85%
More ▼
Data from 30 Jun 2024 - 14 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.